ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,431.60
-0.04%
US Tech 100
19,168.00
0.52%
다우존스 지수
38,589.16
-0.15%
Bitcoin
66,287.20
0.14%
Registration Strip Icon for discussion 같은 생각을 가진 투자자들과 토론할 수 있는 활발한 포럼에서 상호 작용하려면 등록하세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. USOTC
  6. Bellicum Pharmaceuticals Inc (PK) (BLCM)

  7. Bellicum Pharmaceuticals Inc (PK) (BLCM) 뉴스

BLCM

Bellicum Pharmaceuticals (PK) (BLCM)

Bellicum Pharmaceuticals Inc (PK)
일자:
정렬 기준:
 검색 관련기사 보기:USOTC:BLCM
일자시간출처헤드라인심볼기업
2024/03/0205:13Edgar (US Regulatory)Form 15-12G - Securities registration termination [Section 12(g)]USOTC:BLCMBellicum Pharmaceuticals Inc (PK)
2024/02/2714:18Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessUSOTC:BLCMBellicum Pharmaceuticals Inc (PK)
2024/02/2714:16Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessUSOTC:BLCMBellicum Pharmaceuticals Inc (PK)
2024/02/2714:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessUSOTC:BLCMBellicum Pharmaceuticals Inc (PK)
2024/02/2714:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessUSOTC:BLCMBellicum Pharmaceuticals Inc (PK)
2024/02/2714:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessUSOTC:BLCMBellicum Pharmaceuticals Inc (PK)
2024/02/2714:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessUSOTC:BLCMBellicum Pharmaceuticals Inc (PK)
2024/02/2206:07Edgar (US Regulatory)Form 8-K - Current reportUSOTC:BLCMBellicum Pharmaceuticals Inc (PK)
2023/12/1506:30Edgar (US Regulatory)Form 8-K - Current reportUSOTC:BLCMBellicum Pharmaceuticals Inc (PK)
2023/11/2222:26Edgar (US Regulatory)Form 8-K - Current reportUSOTC:BLCMBellicum Pharmaceuticals Inc (PK)
2023/11/1506:24Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]USOTC:BLCMBellicum Pharmaceuticals Inc (PK)
2023/09/3002:13Edgar (US Regulatory)Form 8-K - Current reportUSOTC:BLCMBellicum Pharmaceuticals Inc (PK)
2023/08/1105:30Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]USOTC:BLCMBellicum Pharmaceuticals Inc (PK)
2020/02/0707:29Edgar (US Regulatory)Current Report Filing (8-k)USOTC:BLCMBellicum Pharmaceuticals Inc (PK)
2020/02/0607:21Edgar (US Regulatory)Current Report Filing (8-k)USOTC:BLCMBellicum Pharmaceuticals Inc (PK)
2020/02/0504:26Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:BLCMBellicum Pharmaceuticals Inc (PK)
2020/02/0504:24Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:BLCMBellicum Pharmaceuticals Inc (PK)
2020/02/0504:21Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:BLCMBellicum Pharmaceuticals Inc (PK)
2020/02/0503:20Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:BLCMBellicum Pharmaceuticals Inc (PK)
2020/02/0503:04Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:BLCMBellicum Pharmaceuticals Inc (PK)
2020/02/0407:11Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:BLCMBellicum Pharmaceuticals Inc (PK)
2020/01/3006:57Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)USOTC:BLCMBellicum Pharmaceuticals Inc (PK)
2020/01/2507:19Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)USOTC:BLCMBellicum Pharmaceuticals Inc (PK)
2020/01/2121:59Edgar (US Regulatory)Current Report Filing (8-k)USOTC:BLCMBellicum Pharmaceuticals Inc (PK)
2020/01/1606:44Edgar (US Regulatory)Current Report Filing (8-k)USOTC:BLCMBellicum Pharmaceuticals Inc (PK)
2020/01/0707:16Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:BLCMBellicum Pharmaceuticals Inc (PK)
2020/01/0707:01Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:BLCMBellicum Pharmaceuticals Inc (PK)
2020/01/0706:29Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:BLCMBellicum Pharmaceuticals Inc (PK)
2020/01/0107:16Edgar (US Regulatory)Current Report Filing (8-k)USOTC:BLCMBellicum Pharmaceuticals Inc (PK)
2019/12/1920:11Edgar (US Regulatory)Current Report Filing (8-k)USOTC:BLCMBellicum Pharmaceuticals Inc (PK)
 검색 관련기사 보기:USOTC:BLCM

최근 히스토리

AMEX
SPY
SPDR S&P 500
CCOM
SILVER
SILVER
USOTC
BASFY
BASF (QX)
CCOM
US30
US 30
NASDAQ
QQQ
Invesco QQQ Trust Series 1
USOTC
BNPQY
BNP Paribas (QX)
CCOM
US100
US Tech 100
USI
USTECH100
US Tech 100
CCOM
US500
US 500
NYSE
AXP
American Express
NYSE
JPM
JP Morgan Chase
USOTC
ADDYY
Adidas (QX)
NYSE
BAC
Bank of America
FX
USDGBP
US Dollar vs Sterling
NYSE
VZ
Verizon Communications
NYSE
NKE
Nike
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

대한민국
회사 소개
사업
Popular
앱 받기
App Store
Google Play

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유